We are live on ! Find out more
OPCH icon

Option Care Health

364 hedge funds and large institutions have $5.22B invested in Option Care Health in 2025 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 121 increasing their positions, 142 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more call options, than puts

Call options by funds: $40M | Put options by funds: $24.2M

15% more capital invested

Capital invested by funds: $4.56B → $5.22B (+$662M)

1.99% more ownership

Funds ownership: 101.17%103.17% (+2%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

4% less funds holding

Funds holding: 381364 (-17)

15% less repeat investments, than reductions

Existing positions increased: 121 | Existing positions reduced: 142

15% less first-time investments, than exits

New positions opened: 61 | Existing positions closed: 72

Holders
364
Holders Change
-17
Holders Change %
-4.46%
% of All Funds
4.43%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
61
Increased
121
Reduced
142
Closed
72
Calls
$40M
Puts
$24.2M
Net Calls
+$15.8M
Net Calls Change
+$13.1M
Name Holding Trade Value Shares
Change
Change in
Stake
MFS
226
Mirabella Financial Services
United Kingdom
$323K -$88.2K -3,004 -23%
Mariner
227
Mariner
Kansas
$321K +$19.5K +663 +7%
CIP
228
Cornerstone Investment Partners
Georgia
$311K +$9.33K +318 +3%
Marshall Wace
229
Marshall Wace
United Kingdom
$309K +$285K +9,695 New
JCM
230
Janney Capital Management
Pennsylvania
$295K +$4.64K +158 +2%
BTI
231
Blue Trust Inc
Georgia
$293K +$19.9K +679 +8%
PFBT
232
Parkside Financial Bank & Trust
Missouri
$278K +$21.4K +728 +9%
PCP
233
Perbak Capital Partners
United Kingdom
$272K -$314K -10,693 -56%
TRCT
234
Tower Research Capital (TRC)
New York
$272K -$260K -8,849 -51%
QCG
235
Quadrant Capital Group
Ohio
$262K +$146K +4,965 +152%
Cambridge Investment Research Advisors
236
Cambridge Investment Research Advisors
Iowa
$249K -$31.4K -1,070 -12%
SLAM
237
Swiss Life Asset Management
$249K
PCM
238
Prelude Capital Management
New York
$239K +$220K +7,495 New
Two Sigma Advisers
239
Two Sigma Advisers
New York
$233K -$14.1M -481,500 -99%
M&T Bank
240
M&T Bank
New York
$232K +$214K +7,287 New
AWM
241
Avior Wealth Management
Nebraska
$229K -$37.7K -1,283 -15%
EWA
242
EP Wealth Advisors
California
$225K +$207K +7,067 New
AC
243
AXQ Capital
New Jersey
$220K -$974K -33,177 -83%
RGF
244
Retirement Guys Formula
Ohio
$218K +$201K +6,857 New
DWM
245
Dakota Wealth Management
Florida
$217K +$200K +6,808 New
PA
246
Profund Advisors
Maryland
$212K +$195K +6,645 New
DekaBank Deutsche Girozentrale
247
DekaBank Deutsche Girozentrale
Germany
$211K
KeyBank National Association
248
KeyBank National Association
Ohio
$205K +$189K +6,426 New
EI
249
Ethic Inc
New York
$204K +$188K +6,399 New
FAM
250
Fred Alger Management
New York
$202K +$186K +6,345 New

OPCH Hedge Fund Activity: Q4 2025 in Review

364 of the 8,224 institutional investors tracked by Wall St. Rank reported a position in Option Care Health (OPCH) for Q4 2025, worth a combined $5.22B — up 15% from $4.56B a quarter earlier.

Sellers outnumbered buyers: 72 funds closed out of OPCH and 61 opened new positions — a net loss of 11 holders — while 142 trimmed existing stakes and 121 added.

The largest buyer was Southpoint Capital Advisors, opening a new position worth an estimated $88.1M. The largest seller was Allspring Global Investments, exiting entirely with an estimated $37.8M sold.

  • 364 institutional investors held Option Care Health (OPCH) as of Q4 2025, down from 381 in Q3 2025.
  • Funds reported $5.22B of Option Care Health stock for Q4 2025, up 15% quarter-over-quarter.
  • 61 funds opened new Option Care Health positions in Q4 2025 and 72 closed out, a net change of -11 holders.
  • The largest Option Care Health buyer in Q4 2025 was Southpoint Capital Advisors, an estimated $88.1M added.
  • The largest Option Care Health seller in Q4 2025 was Allspring Global Investments, an estimated $37.8M sold.

Based on aggregated 13F filings for Q4 2025.